National Healthcare
122 hedge funds and large institutions have $495M invested in National Healthcare in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 44 increasing their positions, 52 reducing their positions, and 15 closing their positions.
633% more call options, than puts
Call options by funds: $154K | Put options by funds: $21K
8% more capital invested
Capital invested by funds: $460M → $495M (+$35.1M)
0.87% more ownership
Funds ownership: 44.76% → 45.63% (+0.87%)
6% less funds holding
Funds holding: 130 → 122 (-8)
15% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 52
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
Top Buyers
Top Sellers
| 1 |
Charles Schwab
San Francisco,
California
|
-$4.37M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.12M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.06M |
| 4 |
JP Morgan Chase
New York
|
-$1.42M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.23M |
NHC Hedge Fund Activity: Q1 2022 in Review
122 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in National Healthcare (NHC) for Q1 2022, worth a combined $495M — up 7.6% from $460M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of NHC and 8 opened new positions — a net loss of 7 holders — while 52 trimmed existing stakes and 44 added.
The largest buyer was Invesco, adding an estimated $18.5M. The largest seller was Charles Schwab, cutting an estimated $4.37M.
- 122 institutional investors held National Healthcare (NHC) as of Q1 2022, down from 130 in Q4 2021.
- Funds reported $495M of National Healthcare stock for Q1 2022, up 7.6% quarter-over-quarter.
- 8 funds opened new National Healthcare positions in Q1 2022 and 15 closed out, a net change of -7 holders.
- The largest National Healthcare buyer in Q1 2022 was Invesco, an estimated $18.5M added.
- The largest National Healthcare seller in Q1 2022 was Charles Schwab, an estimated $4.37M sold.
Based on aggregated 13F filings for Q1 2022.